Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0034067 (
emphysema
)
11,506
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Previous study of transgenic mice with long-term expression of
pleiomorphic adenoma gene-like 2
(
PLAGL2
), a surfactant protein C (SP-C) transactivator, in type II cells showed the manifestation of centrilobular
emphysema
in vivo. Since
emphysema
is an independent risk factor for bronchogenic carcinoma, we hypothesized that the mouse lungs with induced
PLAGL2
-expression had increased incidences in developing lung adenocarcinoma. To test the hypothesis, mouse lungs were examined for the presence of tumors. Male mice with induced
PLAGL2
-expression in the lungs were more vulnerable to tumorigenesis than female mice (p<0.05). Epithelial cells expressing pro-SP-C and Clara cell secretory protein (CCSP) at the terminal bronchioles and the bronchoalveolar duct junction (BADJ) were increased in the induced transgenic mice, suggesting a role of
PLAGL2
in expanding SP-C expression cells. Co-expression of TTF-1, pro-SP-C and CD133 (a stem-cell marker) in cancer and distal airway epithelial cells indicated that both cells were derived from common progenitors. This result supported a common-cell-origin mechanism for the comorbid diseases -
emphysema
and lung cancer. Furthermore, a public lung cancer gene expression profiling database was examined to determine the relevance of
PLAGL2
expression and lung adenocarcinoma in humans. Patients with high
PLAGL2
expression in lung tumors were readily found. Female patients (N=218) with low
PLAGL2
expression (the lowest quartile of total patients) at the early-stage of disease had better prognosis in survival. Male patients, on the other hand, had no such correlation. Generally, their survival rate was significantly poorer than of female patients. Taken together, our data suggested a pathological role of
PLAGL2
in lung adenocarcinoma development and a preferable prognosis of low
PLAGL2
expression in female patients.
...
PMID:Pleiomorphic adenoma gene-like 2 expression is associated with the development of lung adenocarcinoma and emphysema. 2139 55